Abstract
The aim of the present study was to evaluate the in vitro activity and cytotoxicity of meglumine antimoniate microspheres produced by spray drying on Leishmania infantum and the effect of the excipients used in them. The parasite strain shows sensitivity to the meglumine antimoniate microspheres prepared. All the antimony IC50 values from encapsulated meglumine antimoniate (3.80 ± 0.34 to 9.53 ± 0.70 μg SbV/ml for promastigotes assay) are considerably lower compared to the mean value of IC50 in Glucantime solution (112 ± 12.74 μg SbV/ml). Interesting IC50 values for the excipient chitosan (112.64 ± 0.53 mg/ml for promastigotes and 100.81 ± 26.45 mg/ml for amastigotes) were obtained (without cytotoxic activity), whereas the rest of the excipients did not show any activity. This new delivery system could offer a new pharmacological tool for the treatment of leishmaniosis that reduces the doses required, lowering toxic side effects because of meglumine antimoniate.
Similar content being viewed by others
References
Basu MK, Lala S (2004) Macrophage specific drug delivery in experimental leishmaniosis. Curr Mol Med 4(6):681–689
Carrió J, de Colmenares M, Riera C, Gállego M, Arboix M, Portús M (2000) Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions. Exp Parasitol 95:209–214
Chirkov SN (2002) The antiviral activity of chitosan. Appl Biochem Microbiol 38(1):5–13 , Translated from Prikladnaya Biokhimiya i Mikrobiologiya
Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G (2004) Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 278:119–131
Demicheli C, Ochoa R, Da Silva JBB, Falçao CAB, Rossi-Bergmann B, De Melo AL, Sinisterra RD, Frézard F (2004) Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniosis. Antimicrob Agents Chemother 48(1):100–103
Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Fauge’re B, Dumon H (1997) In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniosis. Antimicrob Agents Chemother 41(4):827–830
Felt O, Carrel A, Baehni P, Buri P, Gurny R (2000) Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy. J Ocul Pharmacol Ther 16:261–270
Frézard F, Michalick MSM, Soares CF, Demicheli C (2000) Novel methods for the encapsulation meglumine antimoniate into liposomes. Braz J Med Biol Res 33:841–846
Guerin J, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Brycesoniero ADM (2002) Visceral leishmaniosis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet 2:494–501
Guo Z, Chen R, Xing R, Liu S, Yu H, Wang P, Li C, Lia P (2006) Novel derivatives of chitosan and their antifungal activities in vitro. Carbohydr Res 341:351–354
Hejazi R, Amiji M (2003) Chitosan-based gastrointestinal delivery systems. J Control Release 89:151–165
Jumaa M, Furkert FH, Müller BW (2002) A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. Eur J Pharm Biopharm 53:115–123
Kim J, Lee HC, Oh JS, Shin BA, Oh CS, Park RD, Yang KS, Cho CS (1999) Polyelectrolyte complex composed of chitosan and sodium alginate for wound dressing application. J Biomater Sci Polym Ed 10:543–556
Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D (1999) Evidence that the high incidence of treatment failures in Indian Kala-Azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 180:564–567
Ouellette M, Hettema E, Wüst D, Fase-Fowler F, Borst P (1991) Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug resistant Leishmania. EMBO J 10:1009–1016
Perez-Victoria JM, Di Pietro A, Barron D, Ravelo AG, Castanys S, Gamarro F (2002) Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents. Curr Drug Targets 3(4):311–333
Porporatto C, Bianco ID, Riera CM, Correa SG (2003) Chitosan induces different l-arginine metabolic pathways in resting and inflammatory macrophages. Biochem Biophys Res Commun 304:266–272
Prego C, García M, Torres D, Alonso MJ (2005) Transmucosal macromolecular drug delivery. J Control Release 101:151–162
Schettini DA, Costa Val AP, Souza LF, Demicheli C, Rocha OGF, Melo MN, Michalick MSM Frézard F (2003) Distribution of liposome-encapsulated antimony in dogs. Braz J Med Biol Res 36:269–272
Schipper NGM, Varum KM, Artusson P (1996) Chitosan as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (caco-2) cells. Pharm Res 13(11):1686–1692
Tempone AG, Perez D, Rath S, Vilarinho AL, Mortara RA, de Andrade JHF (2004) Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine. J Antimicrob Chemother 54:60–68
Valiathan R, Dubey ML, Mahajan RC, Malla N (2006) Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate. Exp Parasitol 114(2):103–108
Acknowledgments
The authors acknowledge the kind gifts of Glucantime, meglumine antimoniate powder, chitosan, and Lecimuthin from the suppliers Merial, Aventis Pharma, Bioiberica, and Degussa Texturant Systems, respectively. Thanks are also due to R. Rycroft for language editing.
G. Pujals was supported by a grant from the University of Barcelona (PDI 2005–2008). The experiments comply with the current laws of Spain.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pujals, G., Suñé-Negre, J.M., Pérez, P. et al. In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum . Parasitol Res 102, 1243–1247 (2008). https://doi.org/10.1007/s00436-008-0901-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-008-0901-z